Reflect Scientific provides cryogenic cooling for the biotechnology, medical, pharmaceutical, extraction and transportation markets through low-temperature freezers, rapid blast freezers, and ethanol chilling systems for laboratory, drug production, extraction, and transportation uses. The company serves both proprietary markets and OEM channels, leveraging decades of expertise in scientific equipment manufacturing and cryogenic innovation.
Cyborg Score Rationale
Reflect Scientific operates in growing markets (cryogenic cooling for biotech/pharma) with differentiated patented technology, but faces challenges as a micro-cap OTC company with limited analyst coverage, volatile stock performance, and apparent execution headwinds reflected in market positioning.
Top Insights
Cryometrix product line is protected by over 30 patents related to liquid nitrogen technology
Cryometrix ultra-low temperature and blast freezers are used to store critical products including blood and cancer vaccines
Company announced market transitions and cost-saving initiatives in May 2025, including receipt of over $250,000 in orders and completion of major installations
Reflect Scientific is covered by 0 analysts with no consensus estimates available
Named Competitors
Ultra-Low Temperature Freezers — Diversified laboratory equipment and biotech consumables
Cryogenic Storage Systems — Life science laboratory equipment and consumables
Refrigeration Solutions — Chemicals, equipment, and services for life sciences
Recent Developments
(May 2025) Announced successful completion of major installations and received over $250,000 in orders
(May 2025) Announced strategic market transitions and cost-saving initiatives
(May 2025) Received U.S. Patent for innovative computer room cooling system
Open the full interactive Reflect Scientific, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.